rs575836707

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_153827.5(MINK1):​c.*594G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00171 in 144,636 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.0017 ( 0 hom., cov: 29)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

MINK1
NM_153827.5 3_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.422

Publications

0 publications found
Variant links:
Genes affected
MINK1 (HGNC:17565): (misshapen like kinase 1) This gene encodes a serine/threonine kinase belonging to the germinal center kinase (GCK) family. The protein is structurally similar to the kinases that are related to NIK and may belong to a distinct subfamily of NIK-related kinases within the GCK family. Studies of the mouse homolog indicate an up-regulation of expression in the course of postnatal mouse cerebral development and activation of the cJun N-terminal kinase (JNK) and the p38 pathways. [provided by RefSeq, Mar 2016]
CHRNE (HGNC:1966): (cholinergic receptor nicotinic epsilon subunit) Acetylcholine receptors at mature mammalian neuromuscular junctions are pentameric protein complexes composed of four subunits in the ratio of two alpha subunits to one beta, one epsilon, and one delta subunit. The acetylcholine receptor changes subunit composition shortly after birth when the epsilon subunit replaces the gamma subunit seen in embryonic receptors. Mutations in the epsilon subunit are associated with congenital myasthenic syndrome. [provided by RefSeq, Sep 2009]
CHRNE Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: Illumina
  • congenital myasthenic syndrome 4A
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • congenital myasthenic syndrome 4B
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • congenital myasthenic syndrome 4C
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BS2
High AC in GnomAd4 at 247 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MINK1NM_153827.5 linkc.*594G>A 3_prime_UTR_variant Exon 32 of 32 ENST00000355280.11 NP_722549.2 Q8N4C8-1
CHRNENM_000080.4 linkc.*855C>T 3_prime_UTR_variant Exon 12 of 12 ENST00000649488.2 NP_000071.1 Q04844

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MINK1ENST00000355280.11 linkc.*594G>A 3_prime_UTR_variant Exon 32 of 32 1 NM_153827.5 ENSP00000347427.6 Q8N4C8-1
CHRNEENST00000649488.2 linkc.*855C>T 3_prime_UTR_variant Exon 12 of 12 NM_000080.4 ENSP00000497829.1 Q04844

Frequencies

GnomAD3 genomes
AF:
0.00172
AC:
248
AN:
144554
Hom.:
0
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.000411
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00101
Gnomad ASJ
AF:
0.00498
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000860
Gnomad FIN
AF:
0.000110
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00286
Gnomad OTH
AF:
0.00304
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
646
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
356
African (AFR)
AF:
0.00
AC:
0
AN:
4
American (AMR)
AF:
0.00
AC:
0
AN:
4
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
0.00
AC:
0
AN:
30
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
234
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
350
Other (OTH)
AF:
0.00
AC:
0
AN:
22
GnomAD4 genome
AF:
0.00171
AC:
247
AN:
144636
Hom.:
0
Cov.:
29
AF XY:
0.00169
AC XY:
118
AN XY:
69874
show subpopulations
African (AFR)
AF:
0.000410
AC:
16
AN:
39046
American (AMR)
AF:
0.00101
AC:
14
AN:
13906
Ashkenazi Jewish (ASJ)
AF:
0.00498
AC:
17
AN:
3412
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5068
South Asian (SAS)
AF:
0.000864
AC:
4
AN:
4628
European-Finnish (FIN)
AF:
0.000110
AC:
1
AN:
9106
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
272
European-Non Finnish (NFE)
AF:
0.00285
AC:
189
AN:
66324
Other (OTH)
AF:
0.00302
AC:
6
AN:
1990
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.442
Heterozygous variant carriers
0
11
22
32
43
54
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00198
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Congenital myasthenic syndrome Uncertain:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
7.5
DANN
Benign
0.63
PhyloP100
0.42
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs575836707; hg19: chr17-4801176; API